Changes of substance P during fracture healing in ovariectomized mice

Regulatory Peptides

Volumn 159, Issue 1-3, 2010, Pages 28-34

  Ding, Wen Ge ^a   Zhang, Zi Ming ^a   Zhang, Yue Hui ^a   Jiang, Sheng Dan ^a   Jiang, Lei Sheng ^a   Dai, Li Yang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Fracture healing; Osteoporosis; Ovariectomy; Substance P

Indexed keywords

SUBSTANCE P;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE MINERALIZATION; CALLUS; CONTROLLED STUDY; FEMALE; FEMUR SHAFT FRACTURE; FRACTURE HEALING; FRAGILITY FRACTURE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL;

ANIMALS; BONE DENSITY; BONY CALLUS; FEMALE; FEMORAL FRACTURES; FRACTURE HEALING; MICE; OSTEOPOROSIS; OVARIECTOMY; SUBSTANCE P;

MUS;

EID: 71349087748     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.11.004     Document Type: Article

References (41)

1. Johnell O., and Kanis J.A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17 (2006) 1726-1733
2. Namkung-Matthai H., Appleyard R., Jansen J., Hao Lin J., Maastricht S., Swain M., Mason R.S., Murrell G.A., Diwan A.D., and Diamond T. Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone 28 (2001) 80-86
3. Nordin B.E., Need A.G., Chatterton B.E., Horowitz M., and Morris H.A. The relative contributions of age and years since menopause to postmenopausal bone loss. J Clin Endocrinol Metab 70 (1990) 83-88
4. Langeland N. Effects of oestradiol-17β benzoate treatment on fracture healing and bone collagen synthesis in female rats. Acta Endocrinol 80 (1975) 603-612
5. Lindholm T.S. Effects of 1α-hydroxycholecalciferol on osteoporotic changes induced by calcium deficiency in bone fractures in adult rats. J Trauma 18 (1978) 336-340
6. Li J., Ahmad T., Spetea M., Ahmed M., and Kreicbergs A. Bone reinnervation after fracture: a study in the rat. J Bone Miner Res 16 (2001) 1505-1510
7. Hukkanen M., Konttinen Y.T., Santavirta S., Nordsletten L., Madsen J.E., Almaas R., Oestreicher A.B., Rootwelt T., and Polak J.M. Effect of sciatic nerve section on neural ingrowth into the rat tibial fracture callus. Clin Orthop Relat Res 311 (1995) 247-257
8. Hill E.L., Turner R., and Elde R. Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats. Neuroscience 44 (1991) 747-755
9. Burt-Pichat B., Lafage-Proust M.H., Duboeuf F., Laroche N., Itzstein C., Vico L., Delmas P.D., and Chenu C. Dramatic decrease of innervation density in bone after ovariectomy. Endocrinology 146 (2005) 503-510
10. Cherruau M., Facchinetti P., Baroukh B., and Saffar J.L. Chemical sympathectomy impairs bone resorption in rats: a role for the sympathetic system on bone metabolism. Bone 25 (1999) 545-551
11. Edoff K., Hellman J., Persliden J., and Hildebrand C. The developmental skeletal growth in the rat foot is reduced after denervation. Anat Embryol (Berl) 195 (1997) 531-538
12. Jiang S.D., Jiang L.S., and Dai L.Y. Spinal cord injury causes more damage to bone mass, bone structure, biomechanical properties and bone metabolism than sciatic neurectomy in young rats. Osteoporos Int 17 (2006) 1552-1561
13. Jiang S.D., Jiang L.S., and Dai L.Y. Changes in bone mass, bone structure, bone biomechanical properties, and bone metabolism after spinal cord injury: a 6-month longitudinal study in growing rats. Calcif Tissue Int 80 (2007) 167-175
14. Jiang S.D., Jiang L.S., and Dai L.Y. Effects of spinal cord injury on osteoblastogenesis, osteoclastogenesis and gene expression profiling in osteoblasts in young rats. Osteoporos Int 18 (2007) 339-349
15. Liu D., Zhao C.Q., Li H., Jiang S.D., Jiang L.S., and Dai L.Y. Effects of spinal cord injury and hindlimb immobilization on sublesional and supralesional bones in young growing rats. Bone 43 (2008) 119-125
16. Otsuka M., and Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev 73 (1993) 229-308
17. Bjurholm A., Kreicbergs A., Brodin E., and Schultzberg M. Substance P- and CGRP-immunoreactive nerves in bone. Peptides 9 (1988) 165-171
18. Liu D., Li H., Zhao C.Q., Jiang L.S., and Dai L.Y. Changes of substance P-immunoreactive nerve fiber innervation density in the sublesional bones in young growing rats at an early stage after spinal cord injury. Osteoporos Int 19 (2008) 559-569
19. Liu D., Jiang L.S., and Dai L.Y. Substance P and its receptors in bone metabolism. Neuropeptides 41 (2007) 271-283
20. Mori T., Ogata T., Okumura H., Shibata T., Nakamura Y., and Kataoka K. Substance P regulates the function of rabbit cultured osteoclast; increase of intracellular free calcium concentration and enhancement of bone resorption. Biochem Biophys Res Commun 262 (1999) 418-422
21. Bonnarens F., and Einhorn T.A. Production of a standard closed fracture in laboratory animal bone. J Orthop Res 2 (1984) 97-101
22. Manigrasso M.B., and O'Connor J.P. Characterization of a closed femur fracture model in mice. J Orthop Trauma 18 (2004) 687-695
23. Street J., Bao M., deGuzman L., Bunting S., Peale Jr. F.V., Ferrara N., Steinmetz H., Hoeffel J., Cleland J.L., Daugherty A., van Bruggen N., Redmond H.P., Carano R.A., and Filvaroff E.H. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99 (2002) 9656-9661
24. Guldberg R.E., Ballock R.T., Boyan B.D., Duvall C.L., Lin A.S., Nagaraja S., Oest M., Phillips J., Porter B.D., Robertson G., and Taylor W.R. Analyzing bone, blood vessels, and biomaterials with microcomputed tomography. IEEE Eng Med Biol Mag 22 (2003) 77-83
25. Kingery W.S., Offley S.C., Guo T.Z., Davies M.F., Clark J.D., and Jacobs C.R. A substance P receptor (NK1) antagonist enhances the widespread osteoporotic effects of sciatic nerve section. Bone 33 (2003) 927-936
26. Offley S.C., Guo T.Z., Wei T., Clark J.D., Vogel H., Lindsey D.P., Jacobs C.R., Yao W., Lane N.E., and Kingery W.S. Capsaicin-sensitive sensory neurons contribute to the maintenance of trabecular bone integrity. J Bone Miner Res 20 (2005) 257-267
27. Hukkanen M., Konttinen Y.T., Santavirta S., Paavolainen P., Gu X.H., Terenghi G., and Polak J.M. Rapid proliferation of calcitonin gene-related peptide-immunoreactive nerves during healing of rat tibial fracture suggests neural involvement in bone growth and remodelling. Neuroscience 54 (1993) 969-979
28. Li J., Kreicbergs A., Bergstrom J., Stark A., and Ahmed M. Site-specific CGRP innervation coincides with bone formation during fracture healing and modeling: a study in rat angulated tibia. J Orthop Res 25 (2007) 1204-1212
29. Rusanen M., Korkala O., Gronblad M., Partanen S., and Nederstrom A. Evolution of substance P immunofluorescent nerves in callus tissue during fracture healing. J Trauma 27 (1987) 1340-1343
30. Dufourny L., and Warembourg M. Estrogen modulation of neuropeptides: somatostatin, neurotensin and substance P, in the ventrolateral and arcuate nuclei of the female guinea pig. Neurosci Res 33 (1999) 223-228
31. Azuma H., Kido J., Ikedo D., Kataoka M., and Nagata T. Substance P enhances the inhibition of osteoblastic cell differentiation induced by lipopolysaccharide from Porphyromonas gingivalis. J Periodontol 75 (2004) 974-981
32. Adamus M.A., and Dabrowski Z.J. Effect of the neuropeptide substance P on the rat bone marrow-derived osteogenic cells in vitro. J Cell Biochem 81 (2001) 499-506
33. Goto T., Nakao K., Gunjigake K.K., Kido M.A., Kobayashi S., and Tanaka T. Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors. Neuropeptides 41 (2007) 25-31
34. Villa I., Mrak E., Rubinacci A., Ravasi F., and Guidobono F. CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway. Am J Physiol Cell Physiol 291 (2006) C529-C537
35. Sohn S.J. Substance P upregulates osteoclastogenesis by activating nuclear factor kappa B in osteoclast precursors. Acta Otolaryngol 125 (2005) 130-133
36. Quartara L., and Maggi C.A. The tachykinin NK1 receptor. Part II: distribution and pathophysiological roles. Neuropeptides 32 (1998) 1-49
37. Bowden J.J., Garland A.M., Baluk P., Lefevre P., Grady E.F., Vigna S.R., Bunnett N.W., and McDonald D.M. Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation. Proc Natl Acad Sci USA 91 (1994) 8964-8968
38. Kingery W.S., Davies M.F., and Clark J.D. A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II. Pain 104 (2003) 75-84
39. Guo T.Z., Offley S.C., Boyd E.A., Jacobs C.R., and Kingery W.S. Substance P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional pain syndrome type I. Pain 108 (2004) 95-107
40. Garcia-Sanz A., Rodriguez-Barbero A., Bentley M.D., Ritman E.L., and Romero J.C. Three-dimensional microcomputed tomography of renal vasculature in rats. Hypertension 31 (1998) 440-444
41. Bentley M.D., Ortiz M.C., Ritman E.L., and Romero J.C. The use of microcomputed tomography to study microvasculature in small rodents. Am J Physiol Regul Integr Comp Physiol 282 (2002) R1267-R1279